Skip Navigation

Your online source for Hepatitis C and Opioid Treatment Programs

Library


arrowAdult Viral Hepatitis CoordinatorsInfo. for Clinicians icon

Go to page



arrowAmericans with Disabilities ActInfo. for both Clinicians and Patients icon

Go to page



arrowAASLD PRACTICE GUIDELINEInfo. for Clinicians icon

Diagnosis, Management, and Treatment of Hepatitis C

View PDF document



arrowAspects of HIV and HCVInfo. for both Clinicians and Patients icon

Go to page



arrowThe Biopsy Report: A Patient's GuideInfo. for Patients icon

View PDF document



arrowBooksInfo. for both Clinicians and Patients icon

Go to page



arrowBurden of Hepatitis C Infection: Realities and ChallengesInfo. for Clinicians icon

Hashem B. El-Serag, MD, MPH


View PDF document



arrowCAM and Hepatitis C: A Focus on Herbal SupplementsInfo. for Patients icon

View PDF document



arrowCare for Patients Coinfected with HIV-HCV: New Consensus Guidelines from an International PanelInfo. for Clinicians icon

View document



arrowChronic Hepatitis C in the Latino populationInfo. for both Clinicians and Patients icon

View PDF document



arrowChronic hepatitis C in Minority PopulationsInfo. for both Clinicians and Patients icon

View PDF document



arrowChronic Hepatitis C During PregnancyInfo. for both Clinicians and Patients icon

Go to page



arrowConsequences of Hepatitis C Virus (HCV):
Costs of a Baby Boomer Epidemic of Liver Disease Info. for both Clinicians and Patients icon

View PDF document



arrowCounseling GuidelinesInfo. for Clinicians icon

Go to page



arrowDiet and Your LiverInfo. for Patients icon

Go to page



arrowDisability Benefits Available from the Social Security AdministrationInfo. for both Clinicians and Patients icon

View PDF document



arrowEffects of Pegylated Interferon Alfa-2b on the Pharmacokinetic and Pharmacodynamic Properties of Methadone:Info. for Clinicians icon

A Prospective, Nonrandomized, Crossover Study in Patients Coinfected with Hepatitis C and HIV Receiving Methadone Maintenance Treatment

View PDF document



arrowEpidemiology, Modes of Transmission, & Risk Factors for Hepatitis C Virus (HCV) InfectionInfo. for Clinicians icon

View PDF document



arrowEstimating Future Hepatitis C Morbidity, Mortality, and Costs in the United StatesInfo. for Clinicians icon

View PDF document



arrowFacing Hepatitis C, Info You Need (downloadable brochure)Info. for both Clinicians and Patients icon

Download Brochure



arrowGlossaryInfo. for both Clinicians and Patients icon

Go to page



arrowHALT-C Trial Shows Minimal Long-term Benefit of Pegylated Interferon Alfa-2a (Pegasys) Maintenance Therapy in Patients with Chronic Hepatitis CInfo. for both Clinicians and Patients icon

View PDF document



arrowHepatitis AInfo. for both Clinicians and Patients icon

Go to page



arrowHepatitis BInfo. for both Clinicians and Patients icon

Go to page



arrowHerbs that may Harm the LiverInfo. for Patients icon

Go to page



arrowInterferon Alpha Therapy for Hepatitis C: Treatment Completion and Response Rates Among Patients with Substance Use DisordersInfo. for Clinicians icon

Go to page



arrowMedication and the LiverInfo. for Patients icon

Go to page



arrowMeta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and PlaceInfo. for Clinicians icon

Holly Hagan, Enrique R. Pouget, Don C. Des Jarlais, and Corina Lelutiu-Weinberger

View PDF document



arrowNational Institutes of HealthInfo. for both Clinicians and Patients icon

Consensus Development Conference Statement
Management of Hepatitis C: 2002
June 10–12, 2002

View PDF document



arrowNational Institutes of Health Consensus Development Conference Statement:
Management of Hepatitis BInfo. for both Clinicians and Patients icon

View PDF document



arrowNew Directions in Hepatitis C Therapy: A Look at the Evolving Therapeutic ArsenalInfo. for both Clinicians and Patients icon

View PDF document



arrowOngoing Challenges in the Management of Chronic Hepatitis CInfo. for both Clinicians and Patients icon

View PDF document



arrowPain Killers and the LiverInfo. for Patients icon

Go to page



arrowProduct DevelopmentInfo. for both Clinicians and Patients icon

Go to page



arrowSuccessful Treatment of Chronic Hepatitis C with Pegylated Interferon in Combination with Ribavirin in a Methadone Maintenance Treatment ProgramInfo. for Clinicians icon

View PDF document



arrowTreatment for Co-occurring Substance Abuse and Hepatitis CInfo. for Clinicians icon

View PDF document



arrowTreating the Methadone PatientInfo. for Clinicians icon

View PDF document



arrowWhat's Cirrhosis?Info. for both Clinicians and Patients icon

Go to page